Skip to main navigation

Investors & Media Social Media

About
Our Medicines
- Reblozyl^®
Science & Pipeline
- Pipeline
- Luspatercept
- Sotatercept
- ACE-083
- Publications
Patients
Careers
Investors & Media

Investors & Media

Investors & Media

Investor Relations

Investors & Media Home
Press Releases
Events & Presentations
- Upcoming Events
- Archived Events
Analyst Coverage
Stock Information
- Historic Stock Lookup
SEC Filings
Annual Meeting
Corporate Governance
Investor FAQs

Email Alerts

Facebook
Google
LinkedIn
Twitter
RSS

Investor contact:

Todd James, IRC
Vice President, Investor Relations and Corporate Communications
investor@acceleronpharma.com

Media contact:

Matt Fearer
Director, Corporate Communications
mfearer@acceleronpharma.com

SEC Filings

Group

Filing year

Filing date	Form	Description	View
Aug 10, 2004	REGDEX	REGDEX	View HTML
Feb 17, 2004	REGDEX	REGDEX	View HTML

Pagination

First page
Previous page
…
Page 55
Page 56
Page 57
Page 58
Page 59
Page 60
Page 61
Page 62
Current page 63

Copyright Morningstar

128 Sidney Street
Cambridge, MA 02139
Tel: (617) 649-9200
Contact Us

Sitemap
Community Guidelines
Privacy Policy

©2019 Acceleron Pharma, Inc. All Rights Reserved.